Nasdaq Prof News Today

Profound Medical (NASDAQ:PROF – Get Free Report) and Femasys (NASDAQ:FEMY – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, analyst recommendations, profitability, dividends, institutional ownership and risk. Valuation and Earnings This table compares Profound Medical […]

Timelo Investment Management Inc. lessened its position in Profound Medical Corp. (NASDAQ:PROF – Free Report) by 9.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 611,758 shares of the company’s stock after selling 61,400 shares during the quarter. Profound Medical makes up about […]

Letko Brosseau & Associates Inc. reduced its stake in Profound Medical Corp. (NASDAQ:PROF – Free Report) by 0.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,164,125 shares of the company’s stock after selling 4,150 shares during the quarter. Letko Brosseau & Associates Inc. […]

Profound Medical (NASDAQ:PROF – Get Free Report) and BlueRiver Acquisition (NYSE:BLUA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability. Earnings & Valuation This table compares Profound […]

Profound Medical Corp. (NASDAQ:PROF – Free Report) – Analysts at Raymond James issued their Q1 2025 earnings per share (EPS) estimates for Profound Medical in a report released on Thursday, January 25th. Raymond James analyst R. Sarugaser forecasts that the company will earn ($0.21) per share for the quarter. The consensus estimate for Profound Medical’s […]

Profound Medical (NASDAQ:PROF – Get Free Report) and Pulmonx (NASDAQ:LUNG – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership. Institutional and Insider Ownership 35.9% of Profound Medical […]

Profound Medical Corp. (NASDAQ:PROF – Get Free Report)’s stock price fell 1% during mid-day trading on Thursday . The stock traded as low as $9.38 and last traded at $9.44. 4,437 shares traded hands during trading, a decline of 83% from the average session volume of 26,053 shares. The stock had previously closed at $9.54. […]

Profound Medical (NASDAQ:PROF – Get Free Report) is set to post its quarterly earnings results after the market closes on Wednesday, August 9th. Analysts expect Profound Medical to post earnings of ($0.31) per share for the quarter. Profound Medical (NASDAQ:PROF – Get Free Report) last announced its quarterly earnings results on Wednesday, May 10th. The […]

Profound Medical Corp. (NASDAQ:PROF – Get Free Report) saw a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 256,600 shares, a decrease of 27.1% from the June 15th total of 351,900 shares. Based on an average daily volume of 30,600 shares, the short-interest ratio […]

Zweig DiMenna Associates LLC trimmed its position in shares of Profound Medical Corp. (NASDAQ:PROF – Free Report) by 29.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 210,775 shares of the company’s stock after selling 85,892 shares during the period. Zweig […]